Looking back

Hradecky, George
August 2006
Pharmaceutical Representative;Aug2006, Vol. 36 Issue 8, p3
The article recalls notable events in the past 35 years of operation of the journal "Pharmaceutical Representative" in the U.S. In January 1971, the journal "Pharmaceutical Salesman" was launched by McKnight Medical Communications Inc. Representatives and sales executives consider the past years as the golden age of pharmaceutical sales. Those years witnessed changes in the magazine's focus from news to how-to-articles, particularly on the specific sales skills needed to promote drugs.


Related Articles

  • Letters to the Editor. Pantello, Ron; Scales, Faren; McCloud, K. // Pharmaceutical Executive;Dec2005, Vol. 25 Issue 12, p18 

    Several letters to the editor in response to the article "Bad Rep?" published in a previous issue of the journal "Pharmaceutical Executive" are presented.

  • Putting Pen to Paper. Trauthwein, Christina // Kitchen & Bath Business;Aug2004, Vol. 51 Issue 8, p4 

    Comments on a letter expressing appreciation as a furniture salesman. Details of the letter; Invitation to readers to share their experiences in the 50th anniversary of the periodical "Kitchen & Bath Business."

  • If a tree falls …. Edwards, Jim // Pharmaceutical Representative;Oct2007, Vol. 37 Issue 10, p26 

    The article offers tips on how to become an effective emotion-based sales personnel in the pharmaceutical industry.

  • Hard at work.  // Pharmaceutical Representative;Aug2007, Vol. 37 Issue 8, p3 

    The article discusses various reports published within the issue including one by Marjorie Brody on becoming a good pharmaceutical sales representative, and another by Sharon L. Marshall on the pros and cons of contract sales.

  • Surveys question efficiency of expanded field forces in accessing and selling doctors.  // Medical Marketing & Media;Feb2000, Vol. 35 Issue 2, p18 

    Reports that two studies are questioning whether the premise and productivity of expanded sales forces of pharmaceutical companies in the United States bring expected returns. Study by Health Strategies Group which revealed that a large percentage of sales calls to high prescribers allow less...

  • When Will the Bubble Burst? Goldberg, Michele; Davenport, Bob; Mortellito, Tiffany // Pharmaceutical Executive;Jan2003, Vol. 23 Issue 1, p44 

    Discusses the 2002 compensation module of the Hay Group's annual Sales Force Effectiveness Study for the pharmaceutical industry. Percentage of companies that expanded their sales forces; Slowdown in the use of contract sales organizations; Pressure on company recruiters to hire additional...

  • Takes one to know one: reps choose top sales forces, tell what makes them tick.  // Medical Marketing & Media;Jun2000, Vol. 35 Issue 6, p6 

    Reports on the top pharmaceutical companies in terms of effectiveness of sales forces. Sales representatives' ranking of the companies; Pfizer; Merck; Bristol-Myer; Glaxo Wellcome; SmithKline Beecham; Eli Lilly.

  • WE CELEBRATE THIRTY-FIVE YEARS OF PHARMACEUTICAL REPRESENTATIVE.  // Pharmaceutical Representative;Aug2006, Vol. 36 Issue 8, p17 

    The article highlights the 35th anniversary of the journal "Pharmaceutical Representative" in 2006 in the U.S. It offers information on several notable events in the past 35 years of pharmaceutical sales, and emphasizes trends in each era. Furthermore, industry veterans' perspectives of...

  • Should you see a drug rep calling on spec? Moore, Peter // Pulse;11/3/2003, Vol. 63 Issue 44, p72 

    Advises physicians on how to deal with visits by pharmaceutical sales representatives. Proper approach to the pharmaceutical industry; Appropriateness of seeing a sales agent without an appointment; Belief on the evidence presented by sales agents; Guidelines followed by drug companies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics